Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(11%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
2
22%
Ph phase_4
2
22%
Ph phase_2
3
33%
Ph phase_3
2
22%

Phase Distribution

2

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(1)
Other(1)

Detailed Status

Completed5
Not yet recruiting1
unknown1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (22.2%)
Phase 23 (33.3%)
Phase 32 (22.2%)
Phase 42 (22.2%)

Trials by Status

completed556%
not_yet_recruiting111%
unknown111%
recruiting111%
terminated111%

Recent Activity

1 active trials
Showing 5 of 9
completedphase_4

A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

NCT04803747
not_yet_recruitingphase_4

Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

NCT07238972
recruitingphase_1

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

NCT07205926
completedphase_3

Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

NCT03374800
completedphase_2

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

NCT04672395
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT04803747Phase 4

A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery

Completed
NCT07238972Phase 4

Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery

Not Yet Recruiting
NCT07205926Phase 1

First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults

Recruiting
NCT03374800Phase 3

Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial

Completed
NCT04672395Phase 2

A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19

Completed
NCT05012787Phase 3

Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases

Terminated
NCT03069859Phase 2

Use of TXA to Prevent Postpartum Hemorrhage

Unknown
NCT00854308Phase 2

A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib)

Completed
NCT01945944Phase 1

Nebulized Hypertonic Saline for Mechanically Ventilated Children

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9